Compare SLQT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | TKNO |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.6M | 236.6M |
| IPO Year | 2020 | 2021 |
| Metric | SLQT | TKNO |
|---|---|---|
| Price | $1.35 | $4.56 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.88 | N/A |
| AVG Volume (30 Days) | ★ 878.2K | 114.8K |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,563,142,000.00 | $39,801,000.00 |
| Revenue This Year | $13.00 | $8.79 |
| Revenue Next Year | $7.65 | $10.52 |
| P/E Ratio | $10.82 | ★ N/A |
| Revenue Growth | ★ 13.16 | 9.50 |
| 52 Week Low | $1.33 | $3.94 |
| 52 Week High | $6.86 | $10.37 |
| Indicator | SLQT | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 46.63 |
| Support Level | $1.35 | $4.53 |
| Resistance Level | $1.46 | $4.86 |
| Average True Range (ATR) | 0.08 | 0.26 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 4.35 | 37.74 |
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.